Multiple sclerosis and depression: a protocol to evaluate online mindfulness-based cognitive therapy

Online therapy could expand options for managing depression in people with multiple sclerosis. But its effectiveness in this population remains to be established. The document describes the protocol for a trial of mindfulness-based cognitive therapy, not clinical results.

Illustration of a mindfulness-based cognitive therapy session attended online.
MindsetEditorial illustration, not study data.

An intervention adapted for multiple sclerosis

Mindfulness-based cognitive therapy, or MBCT, has supporting evidence in recurrent depression in the general population, according to the background presented by the authors. This is not enough to establish its effectiveness in people with multiple sclerosis and mild to moderate depression. That is precisely the uncertainty this project aims to examine.

The planned intervention consists of an eight-week online programme, with weekly sessions led by qualified instructors experienced in supporting people with multiple sclerosis. The aim is to evaluate this structured, adapted programme, not a meditation app used independently.

A randomised trial, with no results available

The protocol plans to include at least 152 people with multiple sclerosis and mild to moderate depression. The randomised trial will compare the intervention with a waitlist control group.

The primary outcome will be depression, assessed using the depression subscale of the Hospital Anxiety and Depression Scale, known as HADS-D. Questionnaires will be collected before the intervention, after it, and three months later. An intention-to-treat analysis is planned.

The abstract presents no changes in symptoms or numerical comparisons between groups. It therefore cannot establish the size of any potential benefit, how long it might last, or how well the programme is tolerated.

Understanding implementation conditions too

The project combines clinical evaluation with an implementation study. Semi-structured interviews are planned with 30 to 40 participants, healthcare professionals, instructors and decision-makers in the field of multiple sclerosis. These are intended to inform adaptations to the programme and the conditions for integrating it into care.

The comparator also imposes a limitation: a waitlist alone will not establish whether this approach is more effective than another psychotherapy. This publication therefore contributes an evaluation plan, not a demonstration of effectiveness.

Limitations to keep in mind

Only the PubMed abstract was consulted, not the full text. No effectiveness or safety results are presented. Funding and conflicts of interest have not been verified in the dossier.

What we can take away

This protocol raises a relevant clinical question, but does not yet support recommending this online MBCT on the basis of results specific to multiple sclerosis.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.